In this systematic review and meta-analysis of 25 randomised controlled trials involving more than 8,000 participants, we found that people allocated to GLP-1 receptor agonists reported lower binge eating symptoms, loss of control eating, eating disinhibition, and emotional eating compared with those allocated to control groups
[25] [26] NICE recommends GLP-1 receptor agonists as second- or third-line therapy for type 2 diabetes when metformin and other oral agents have not achieved adequate control
Clinical trials ensure you are receiving the authentic compound under medical supervision, with appropriate monitoring of your health and safety
This mechanism alone has proven remarkably effective, but Retatrutide does not stop there
Once you reach a healthy weight-loss pace, which is one to two pounds a week, youll stay at that dose until you achieve your healthy weight goal, even if its less than the maximum 2.4mg